Estimation of renal cell carcinoma treatment effects from disease progression modeling.
Maitland, M L
Estimation of renal cell carcinoma treatment effects from disease progression modeling. [electronic resource] - Clinical pharmacology and therapeutics Apr 2013 - 345-51 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Validation Study
1532-6535
10.1038/clpt.2012.263 doi
Antineoplastic Agents--therapeutic use
Carcinoma, Renal Cell--drug therapy
Clinical Trials, Phase II as Topic--statistics & numerical data
Clinical Trials, Phase III as Topic--statistics & numerical data
Disease Progression
Kidney Neoplasms--drug therapy
Models, Statistical
Niacinamide--analogs & derivatives
Phenylurea Compounds--therapeutic use
Sorafenib
Estimation of renal cell carcinoma treatment effects from disease progression modeling. [electronic resource] - Clinical pharmacology and therapeutics Apr 2013 - 345-51 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Validation Study
1532-6535
10.1038/clpt.2012.263 doi
Antineoplastic Agents--therapeutic use
Carcinoma, Renal Cell--drug therapy
Clinical Trials, Phase II as Topic--statistics & numerical data
Clinical Trials, Phase III as Topic--statistics & numerical data
Disease Progression
Kidney Neoplasms--drug therapy
Models, Statistical
Niacinamide--analogs & derivatives
Phenylurea Compounds--therapeutic use
Sorafenib